Literature DB >> 3806087

Stereospecific 3H-QNB binding to human erythrocyte membranes associated with muscarinic cholinergic receptors.

B Bering, W E Müller.   

Abstract

Specific binding of the muscarinic antagonist 3H-QNB can be demonstrated on human erythrocyte membranes. Specific 3H-QNB binding is stereospecific and can be inhibited by a variety of cholinergic agonists and antagonist with affinities similar to their affinities for muscarinic cholinergic receptor binding in other tissues. Accordingly, the data indicate the presence of muscarinic cholinergic receptors on human erythrocyte membranes. Their density is very low, varies between healthy persons, but seems to be an individual characteristic. The data reported are consistent with the assumption that the muscarinic cholinergic receptors on human erythrocyte membranes are mainly of the M1 receptor subtype.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3806087     DOI: 10.1007/bf01244642

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  16 in total

1.  Biochemical characterization of the muscarinic cholinergic receptor in human brain: alterations in Huntington's disease.

Authors:  G J Wastek; H I Yamamura
Journal:  Mol Pharmacol       Date:  1978-09       Impact factor: 4.436

2.  A functional acetylcholine receptor in the human erythrocyte.

Authors:  W H Huestis; H M McConnell
Journal:  Biochem Biophys Res Commun       Date:  1974-04-08       Impact factor: 3.575

3.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

4.  Further characterization of human red blood cell membrane cholinergic receptors.

Authors:  C R Mantione; I Hanin
Journal:  Mol Pharmacol       Date:  1980-07       Impact factor: 4.436

5.  Modulation of muscarinic cholinergic receptor affinity for antagonists in rat heart.

Authors:  M W Martin; M M Smith; T K Harden
Journal:  J Pharmacol Exp Ther       Date:  1984-08       Impact factor: 4.030

6.  Structure and conformation activity relationships of heterocyclic acetylcholine analogues. X. The inhibitory effect of 3-quinuclidinyl benzilates on cardiac muscarinic receptors.

Authors:  G Lambrecht
Journal:  Arzneimittelforschung       Date:  1980

7.  Muscarinic cholinergic binding in rat brain.

Authors:  H I Yamamura; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1974-05       Impact factor: 11.205

8.  Muscarinic cholinergic receptors on skin fibroblasts in familial affective disorder.

Authors:  N S Nadi; J I Nurnberger; E S Gershon
Journal:  N Engl J Med       Date:  1984-07-26       Impact factor: 91.245

9.  Pirenzepine distinguishes between different subclasses of muscarinic receptors.

Authors:  R Hammer; C P Berrie; N J Birdsall; A S Burgen; E C Hulme
Journal:  Nature       Date:  1980-01-03       Impact factor: 49.962

10.  Studies on the relationship of binding affinity to psychoactive and anticholingergic potency of a group of psychotomimetic glycolates.

Authors:  J Baumgold; L G Abood; R Aronstam
Journal:  Brain Res       Date:  1977-03-25       Impact factor: 3.252

View more
  1 in total

1.  Personality factors predisposing to depression correlate significantly negatively with M1-muscarinic and beta-adrenergic receptor densities on blood cells.

Authors:  H W Moises; B Bering; W E Müller
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1988
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.